G W Reuther. Prog Mol Biol Transl Sci 2016
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli,[...]. Nature 2005
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli,[...]. Nature 2005
100
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Ross L Levine, Martha Wadleigh, Jan Cools, Benjamin L Ebert, Gerlinde Wernig, Brian J P Huntly, Titus J Boggon, Iwona Wlodarska, Jennifer J Clark, Sandra Moore,[...]. Cancer Cell 2005
Ross L Levine, Martha Wadleigh, Jan Cools, Benjamin L Ebert, Gerlinde Wernig, Brian J P Huntly, Titus J Boggon, Iwona Wlodarska, Jennifer J Clark, Sandra Moore,[...]. Cancer Cell 2005
100
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
A Tefferi, J W Vardiman. Leukemia 2008
A Tefferi, J W Vardiman. Leukemia 2008
66
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
J Nangalia, C E Massie, E J Baxter, F L Nice, G Gundem, D C Wedge, E Avezov, J Li, K Kollmann, D G Kent,[...]. N Engl J Med 2013
66
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
P Guglielmelli, T L Lasho, G Rotunno, J Score, C Mannarelli, A Pancrazzi, F Biamonte, A Pardanani, K Zoi, A Reiter,[...]. Leukemia 2014
P Guglielmelli, T L Lasho, G Rotunno, J Score, C Mannarelli, A Pancrazzi, F Biamonte, A Pardanani, K Zoi, A Reiter,[...]. Leukemia 2014
66
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
Francesco Passamonti, Chiara Elena, Susanne Schnittger, Radek C Skoda, Anthony R Green, François Girodon, Jean-Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Carles Besses,[...]. Blood 2011
Francesco Passamonti, Chiara Elena, Susanne Schnittger, Radek C Skoda, Anthony R Green, François Girodon, Jean-Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Carles Besses,[...]. Blood 2011
66
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Linda M Scott, Wei Tong, Ross L Levine, Mike A Scott, Philip A Beer, Michael R Stratton, P Andrew Futreal, Wendy N Erber, Mary Frances McMullin, Claire N Harrison,[...]. N Engl J Med 2007
Linda M Scott, Wei Tong, Ross L Levine, Mike A Scott, Philip A Beer, Michael R Stratton, P Andrew Futreal, Wendy N Erber, Mary Frances McMullin, Claire N Harrison,[...]. N Engl J Med 2007
66
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
Robert Kralovics, Francesco Passamonti, Andreas S Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R Passweg, Andre Tichelli, Mario Cazzola, Radek C Skoda. N Engl J Med 2005
66
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin,[...]. Lancet 2005
E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin,[...]. Lancet 2005
66
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
David A Hinds, Kimberly E Barnholt, Ruben A Mesa, Amy K Kiefer, Chuong B Do, Nicholas Eriksson, Joanna L Mountain, Uta Francke, Joyce Y Tung, Huong Marie Nguyen,[...]. Blood 2016
David A Hinds, Kimberly E Barnholt, Ruben A Mesa, Amy K Kiefer, Chuong B Do, Nicholas Eriksson, Joanna L Mountain, Uta Francke, Joyce Y Tung, Huong Marie Nguyen,[...]. Blood 2016
66
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.
A Pardanani, T L Lasho, C Finke, C A Hanson, A Tefferi. Leukemia 2007
A Pardanani, T L Lasho, C Finke, C A Hanson, A Tefferi. Leukemia 2007
33
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Elisa Rumi, Daniela Pietra, Virginia Ferretti, Thorsten Klampfl, Ashot S Harutyunyan, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Chiara Elena, Ilaria C Casetti,[...]. Blood 2014
Elisa Rumi, Daniela Pietra, Virginia Ferretti, Thorsten Klampfl, Ashot S Harutyunyan, Jelena D Milosevic, Nicole C C Them, Tiina Berg, Chiara Elena, Ilaria C Casetti,[...]. Blood 2014
33
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
O Kilpivaara, R L Levine. Leukemia 2008
O Kilpivaara, R L Levine. Leukemia 2008
33
Myeloproliferative Neoplasms: A Contemporary Review.
Ayalew Tefferi, Animesh Pardanani. JAMA Oncol 2015
Ayalew Tefferi, Animesh Pardanani. JAMA Oncol 2015
33
Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients.
C M Butcher, U Hahn, L B To, J Gecz, E J Wilkins, H S Scott, P G Bardy, R J D'Andrea. Leukemia 2008
C M Butcher, U Hahn, L B To, J Gecz, E J Wilkins, H S Scott, P G Bardy, R J D'Andrea. Leukemia 2008
33
From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms.
Mario Cazzola, Robert Kralovics. Blood 2014
Mario Cazzola, Robert Kralovics. Blood 2014
33
Genetic and epigenetic complexity in myeloproliferative neoplasms.
Nicholas C P Cross. Hematology Am Soc Hematol Educ Program 2011
Nicholas C P Cross. Hematology Am Soc Hematol Educ Program 2011
33
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Amy V Jones, Sebastian Kreil, Katerina Zoi, Katherine Waghorn, Claire Curtis, Lingyan Zhang, Joannah Score, Rachel Seear, Andrew J Chase, Francis H Grand,[...]. Blood 2005
Amy V Jones, Sebastian Kreil, Katerina Zoi, Katherine Waghorn, Claire Curtis, Lingyan Zhang, Joannah Score, Rachel Seear, Andrew J Chase, Francis H Grand,[...]. Blood 2005
33
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.
T Barbui, A M Vannucchi, V Buxhofer-Ausch, V De Stefano, S Betti, A Rambaldi, E Rumi, M Ruggeri, F Rodeghiero, M L Randi,[...]. Blood Cancer J 2015
T Barbui, A M Vannucchi, V Buxhofer-Ausch, V De Stefano, S Betti, A Rambaldi, E Rumi, M Ruggeri, F Rodeghiero, M L Randi,[...]. Blood Cancer J 2015
33
Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
Magnus Björkholm, Malin Hultcrantz, Åsa Rangert Derolf. Best Pract Res Clin Haematol 2014
Magnus Björkholm, Malin Hultcrantz, Åsa Rangert Derolf. Best Pract Res Clin Haematol 2014
33
STAT1 activation in association with JAK2 exon 12 mutations.
Anna L Godfrey, Edwin Chen, Charles E Massie, Yvonne Silber, Francesca Pagano, Beatriz Bellosillo, Paola Guglielmelli, Claire N Harrison, John T Reilly, Frank Stegelmann,[...]. Haematologica 2016
Anna L Godfrey, Edwin Chen, Charles E Massie, Yvonne Silber, Francesca Pagano, Beatriz Bellosillo, Paola Guglielmelli, Claire N Harrison, John T Reilly, Frank Stegelmann,[...]. Haematologica 2016
33
Correlations between Janus kinase 2 V617F allele burdens and clinicohematologic parameters in myeloproliferative neoplasms.
Jung-Sook Ha, Yu-Kyung Kim, Soon-Il Jung, He-Ra Jung, In-Sung Chung. Ann Lab Med 2012
Jung-Sook Ha, Yu-Kyung Kim, Soon-Il Jung, He-Ra Jung, In-Sung Chung. Ann Lab Med 2012
33
Emerging treatments for classical myeloproliferative neoplasms.
Alessandro M Vannucchi, Claire N Harrison. Blood 2017
Alessandro M Vannucchi, Claire N Harrison. Blood 2017
33
DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms.
Ana P Azevedo, Susana N Silva, João P De Lima, Alice Reichert, Fernando Lima, Esmeraldina Júnior, José Rueff. Oncol Lett 2017
Ana P Azevedo, Susana N Silva, João P De Lima, Alice Reichert, Fernando Lima, Esmeraldina Júnior, José Rueff. Oncol Lett 2017
33
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.
Elisa Rumi, Mario Cazzola. Blood 2017
Elisa Rumi, Mario Cazzola. Blood 2017
33
Smoking as a contributing factor for development of polycythemia vera and related neoplasms.
Hans Carl Hasselbalch. Leuk Res 2015
Hans Carl Hasselbalch. Leuk Res 2015
33
Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
Ayalew Tefferi. Am J Hematol 2016
Ayalew Tefferi. Am J Hematol 2016
33
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union.
Odile Moulard, Jyotsna Mehta, Jon Fryzek, Robert Olivares, Usman Iqbal, Ruben A Mesa. Eur J Haematol 2014
Odile Moulard, Jyotsna Mehta, Jon Fryzek, Robert Olivares, Usman Iqbal, Ruben A Mesa. Eur J Haematol 2014
33
Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
Gamal T Ebid, Mohamed Ghareeb, Omina Salaheldin, Mahmoud M Kamel. Int J Clin Exp Pathol 2015
Gamal T Ebid, Mohamed Ghareeb, Omina Salaheldin, Mahmoud M Kamel. Int J Clin Exp Pathol 2015
33
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.
Philip A Beer, François Delhommeau, Jean-Pierre LeCouédic, Mark A Dawson, Edwin Chen, David Bareford, Rajko Kusec, Mary Frances McMullin, Claire N Harrison, Alessandro M Vannucchi,[...]. Blood 2010
Philip A Beer, François Delhommeau, Jean-Pierre LeCouédic, Mark A Dawson, Edwin Chen, David Bareford, Rajko Kusec, Mary Frances McMullin, Claire N Harrison, Alessandro M Vannucchi,[...]. Blood 2010
33
Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk.
Susana N Silva, Rita Moita, Ana Paula Azevedo, Rita Gouveia, Isabel Manita, Julieta Esperança Pina, José Rueff, Jorge Gaspar. Cancer Detect Prev 2007
Susana N Silva, Rita Moita, Ana Paula Azevedo, Rita Gouveia, Isabel Manita, Julieta Esperança Pina, José Rueff, Jorge Gaspar. Cancer Detect Prev 2007
33
JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment.
Alessandro M Vannucchi, Lisa Pieri, Paola Guglielmelli. Ther Adv Hematol 2011
Alessandro M Vannucchi, Lisa Pieri, Paola Guglielmelli. Ther Adv Hematol 2011
33
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
Thomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, Hans Carl Hasselbalch. Eur J Haematol 2007
Thomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, Hans Carl Hasselbalch. Eur J Haematol 2007
33
JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.
Camilla Nielsen, Stig E Bojesen, Børge G Nordestgaard, Klaus F Kofoed, Henrik S Birgens. Haematologica 2014
Camilla Nielsen, Stig E Bojesen, Børge G Nordestgaard, Klaus F Kofoed, Henrik S Birgens. Haematologica 2014
33
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.
K L Rice, X Lin, K Wolniak, B L Ebert, W Berkofsky-Fessler, M Buzzai, Y Sun, C Xi, P Elkin, R Levine,[...]. Blood Cancer J 2011
K L Rice, X Lin, K Wolniak, B L Ebert, W Berkofsky-Fessler, M Buzzai, Y Sun, C Xi, P Elkin, R Levine,[...]. Blood Cancer J 2011
33
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
33
Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.
Shashidhar S Jatiani, Stacey J Baker, Lewis R Silverman, E Premkumar Reddy. Genes Cancer 2010
Shashidhar S Jatiani, Stacey J Baker, Lewis R Silverman, E Premkumar Reddy. Genes Cancer 2010
33
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera.
Linda M Scott, Philip A Beer, Anthony J Bench, Wendy N Erber, Anthony R Green. Br J Haematol 2007
Linda M Scott, Philip A Beer, Anthony J Bench, Wendy N Erber, Anthony R Green. Br J Haematol 2007
33
Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.
José Rueff, António Sebastião Rodrigues. Methods Mol Biol 2016
José Rueff, António Sebastião Rodrigues. Methods Mol Biol 2016
33
JAK2-v617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms.
Antica Nacinović Duletić, Andrea Dekanić, Ita Hadzisejdić, Ivona Kusen, Koviljka Matusan-Ilijas, Dragana Grohovac, Blazenka Grahovac, Nives Jonjić. Coll Antropol 2012
Antica Nacinović Duletić, Andrea Dekanić, Ita Hadzisejdić, Ivona Kusen, Koviljka Matusan-Ilijas, Dragana Grohovac, Blazenka Grahovac, Nives Jonjić. Coll Antropol 2012
33
SNPStats: a web tool for the analysis of association studies.
Xavier Solé, Elisabet Guinó, Joan Valls, Raquel Iniesta, Víctor Moreno. Bioinformatics 2006
Xavier Solé, Elisabet Guinó, Joan Valls, Raquel Iniesta, Víctor Moreno. Bioinformatics 2006
33
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population.
Camilla Nielsen, Henrik S Birgens, Børge G Nordestgaard, Lasse Kjaer, Stig E Bojesen. Haematologica 2011
Camilla Nielsen, Henrik S Birgens, Børge G Nordestgaard, Lasse Kjaer, Stig E Bojesen. Haematologica 2011
33
A link between the driver mutations and dysregulated apoptosis in BCR-ABL1 negative myeloproliferative neoplasms.
Cristina Mambet, Lilia Matei, Laura Georgiana Necula, Carmen C Diaconu. J Immunoassay Immunochem 2016
Cristina Mambet, Lilia Matei, Laura Georgiana Necula, Carmen C Diaconu. J Immunoassay Immunochem 2016
33
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
Ayalew Tefferi, Tiziano Barbui. Am J Hematol 2017
Ayalew Tefferi, Tiziano Barbui. Am J Hematol 2017
33
Management of myelofibrosis: JAK inhibition and beyond.
Maximilian Stahl, Amer M Zeidan. Expert Rev Hematol 2017
Maximilian Stahl, Amer M Zeidan. Expert Rev Hematol 2017
33
Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.
Pascual Bolufer, Eva Barragan, Maria Collado, José Cervera, José-Antonio López, Miguel A Sanz. Leuk Res 2006
Pascual Bolufer, Eva Barragan, Maria Collado, José Cervera, José-Antonio López, Miguel A Sanz. Leuk Res 2006
33
Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.
João Conde, Susana N Silva, Ana P Azevedo, Valdemar Teixeira, Julieta Esperança Pina, José Rueff, Jorge F Gaspar. BMC Cancer 2009
João Conde, Susana N Silva, Ana P Azevedo, Valdemar Teixeira, Julieta Esperança Pina, José Rueff, Jorge F Gaspar. BMC Cancer 2009
33
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
F Passamonti, E Rumi, D Pietra, C Elena, E Boveri, L Arcaini, E Roncoroni, C Astori, M Merli, S Boggi,[...]. Leukemia 2010
F Passamonti, E Rumi, D Pietra, C Elena, E Boveri, L Arcaini, E Roncoroni, C Astori, M Merli, S Boggi,[...]. Leukemia 2010
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.